Seed VC · USA

Oncology Ventures

Active

What they invest in

We invest in healthcare data companies tackling the biggest problems in cancer care. The U.S. oncology system is fragmented, expensive, and filled with barriers to evidence-based care. We fund technologies that address this from early detection to patient navigation to data access and AI-powered treatment optimization.

Who they back

DeepTechHealthtechBiotechSeed

Business models

saas_b2b, platform, services

Customer segments

Enterprise, Health plans, Healthcare providers, Hospitals, Cancer care organizations

Geography

US

The people who write checks

4 partners on file at Oncology Ventures, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Oncology Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Oncology Ventures alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Aug 2024
New fund raised (SEC Form D)
Jan 2026, $42M
Website
www.oncology.ventures ↗

Other firms investing in DeepTech

See all investors

Is Oncology Ventures the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Oncology Ventures is one of them, and we'll tell you exactly where they sit in your top 100.